(Q43605765)

25 November 2017

title

Epidural ropivacaine hydrochloride during labour: protein binding, placental transfer and neonatal outcome (English)

1 reference

25 November 2017

Porter JM

1

1 reference

25 November 2017

Kelleher N

series ordinal

2

1 reference

25 November 2017

Flynn R

series ordinal

3

1 reference

25 November 2017

Shorten GD

series ordinal

4

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

25 November 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

Anaesthesia

1 reference

25 November 2017

volume

56

1 reference

25 November 2017

issue

5

1 reference

25 November 2017

page(s)

418-423

1 reference

The plasma protein binding of basic drugs

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.01908.X

Cardiotoxicity of ropivacaine--a new amide local anaesthetic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.01908.X

Clinical effects and maternal and fetal plasma concentrations of epidural ropivacaine versus bupivacaine for cesarean section.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.01908.X

Early time course of the acute phase protein response in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.01908.X

Alpha 1-acid glycoprotein and albumin in human serum bupivacaine binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.01908.X

Displacement of lidocaine from serum alpha 1-acid glycoprotein binding sites by basic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.01908.X

Pharmacokinetic and clinical study of ropivacaine and bupivacaine in women receiving extradural analgesia in labour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.01908.X

Pharmacokinetics and analgesic effect of ropivacaine during continuous epidural infusion for postoperative pain relief

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.01908.X

Ropivacaine 7.5 mg/ml for elective caesarean section. A clinical and pharmacokinetic comparison of 150 mg and 187.5 mg.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.01908.X

Ropivacaine 0.75% for extradural anaesthesia in elective caesarean section: an open clinical and pharmacokinetic study in mother and neonate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.01908.X

Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.01908.X

Neonatal outcome and mode of delivery after epidural analgesia for labour with ropivacaine and bupivacaine: a prospective meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.01908.X

A double-blind comparison of 0.25% ropivacaine and 0.25% bupivacaine for extradural analgesia in labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.01908.X

The Neurologic and Adaptive Capacity Score: a systematic review of its use in obstetric anesthesia research

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.01908.X

Use and abuse of neonatal neurobehavioral testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.01908.X

10.1046/J.1365-2044.2001.01908.X

21 January 2018

Identifiers

DOI

1 reference

25 November 2017

1 reference